Oocyte in vitro maturation (MIV) - An alternative to oncological patients

Autor: Smitz, Johan

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3848::38cc144866c523a756975288368e114d
https://biblio.vub.ac.be/vubir/oocyte-in-vitro-maturation-miv--an-alternative-to-oncological-patients(d031eb7a-0b84-47ad-b16c-8d70495fd746).html

Creating a Global Community of Practice for Oncofertility.

Autor: Ataman LM; Feinberg School of Medicine, Northwestern University, Chicago, IL., Rodrigues JK; Brazilian Oncofertility Consortium, Belo Horizonte, Brazil.; Pró-Criar Medicina Reprodutiva, Belo Horizonte, Brazil., Marinho RM; Brazilian Oncofertility Consortium, Belo Horizonte, Brazil.; Pró-Criar Medicina Reprodutiva, Belo Horizonte, Brazil.; Faculdade de Ciências Médicas de Minas Gerais, Belo Horizonte, Brazil., Caetano JPJ; Brazilian Oncofertility Consortium, Belo Horizonte, Brazil.; Pró-Criar Medicina Reprodutiva, Belo Horizonte, Brazil.; Faculdade de Ciências Médicas de Minas Gerais, Belo Horizonte, Brazil., Chehin MB; Brazilian Oncofertility Consortium, Belo Horizonte, Brazil.; Huntington Reproductive Medicine and Federal University of São Paulo, São Paulo, Brazil., Alves da Motta EL; Brazilian Oncofertility Consortium, Belo Horizonte, Brazil.; Huntington Reproductive Medicine and Federal University of São Paulo, São Paulo, Brazil., Serafini P; Brazilian Oncofertility Consortium, Belo Horizonte, Brazil.; Huntington Reproductive Medicine and Federal University of São Paulo, São Paulo, Brazil., Suzuki N; St Marianna University School of Medicine, Knagawa, Japan., Furui T; Gifu University Graduate School of Medicine, Gifu, Japan., Takae S; St Marianna University School of Medicine, Knagawa, Japan., Sugishita Y; St Marianna University School of Medicine, Knagawa, Japan., Morishige KI; Gifu University Graduate School of Medicine, Gifu, Japan., Almeida-Santos T; University Hospital of Coimbra, Coimbra, Portugal.; University of Coimbra, Coimbra, Portugal., Melo C; University of Coimbra, Coimbra, Portugal., Buzaglo K; Clinique Ovo, Montreal, Quebec, Canada., Irwin K; Cancer Knowledge Network, Milton, Ontario, Canada., Wallace WH; Edinburgh Royal Hospital for Sick Children, Edinburgh, United Kingdom., Anderson RA; Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom., Mitchell RT; Edinburgh Royal Hospital for Sick Children, Edinburgh, United Kingdom.; Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom., Telfer EE; Centres for Fertility Preservation and Integrative Physiology, University of Edinburgh, Edinburgh, United Kingdom., Adiga SK; Kasturba Medical College, Manipal University, Manipal, India., Anazodo A; Sydney Children's and Prince of Wales Hospital, Future Fertility, Randwick, New South Wales, Australia., Stern C; Royal Women's Hospital, University of Melbourne, Melbourne, Victoria, Australia., Sullivan E; University of Technology, Sydney, New South Wales, Australia., Jayasinghe Y; Children's Cancer Centre, Royal Children's Hospital, Parkville, Victoria, Australia., Orme L; Children's Cancer Centre, Royal Children's Hospital, Parkville, Victoria, Australia., Cohn R; Kids Cancer Centre, Sydney Children's Hospital Sydney, New South Wales, Australia.; School of Women's and Children's Health, University of New South Wales, Royal Hospital for Women, Sydney, New South Wales, Australia., McLachlan R; Monash Institute of Medical Research, Prince Henry's Institute, Clayton, Victoria, Australia., Deans R; School of Women's and Children's Health, University of New South Wales, Royal Hospital for Women, Sydney, New South Wales, Australia., Agresta F; Royal Women's Hospital, University of Melbourne, Melbourne, Victoria, Australia., Gerstl B; Sydney Children's and Prince of Wales Hospital, Future Fertility, Randwick, New South Wales, Australia., Ledger WL; School of Women's and Children's Health, University of New South Wales, Royal Hospital for Women, Sydney, New South Wales, Australia., Robker RL; Robinson Research Institute, University of Adelaide, Adelaide, South Australia, Australia., de Meneses E Silva JM; Ceara Blood Center, Centro de Hematologia e Hemoterapia do Ceará, Fortaleza, Brazil.; Assis Chateaubri and Maternity School, Federal University of Ceara, Fortaleza, Brazil., Melo E Silva LHF; Federal University of Ceara and Femini Imagem and Ultravida Clinic, Fortaleza, Brazil., Lunardi FO; State University of Ceara, Fortaleza, Brazil., Lee JR; Seoul National University Bundang Hospital, Seongnam.; Seoul National University College of Medicine, Seoul, Korea., Suh CS; Seoul National University Bundang Hospital, Seongnam.; Seoul National University College of Medicine, Seoul, Korea., De Vos M; Centre for Reproductive Medicine, Universitair Ziekenhuis (UZ) Brussel, Belgium., Van Moer E; Centre for Reproductive Medicine, Universitair Ziekenhuis (UZ) Brussel, Belgium., Stoop D; Centre for Reproductive Medicine, Universitair Ziekenhuis (UZ) Brussel, Belgium., Vloeberghs V; Centre for Reproductive Medicine, Universitair Ziekenhuis (UZ) Brussel, Belgium., Smitz J; Laboratory of Clinical Chemistry and Radioimmunology, UZ Brussel, Brussels, Belgium., Tournaye H; Centre for Reproductive Medicine, Universitair Ziekenhuis (UZ) Brussel, Belgium., Wildt L; Innsbruck Medical University, Innsbruck, Austria., Winkler-Crepaz K; Innsbruck Medical University, Innsbruck, Austria., Andersen CY; Juliane Marie Centre for Women, Children and Reproduction, University Hospital of Copenhagen, Copenhagen, Denmark., Smith BM; Feinberg School of Medicine, Northwestern University, Chicago, IL., Smith K; Feinberg School of Medicine, Northwestern University, Chicago, IL., Woodruff TK; Feinberg School of Medicine, Northwestern University, Chicago, IL.

Publikováno v: JCO global oncology [JCO Glob Oncol] 2020 Nov; Vol. 6, pp. 317-330.

A critical analysis of the impact of endocrine disruptors as a possible etiology of primary ovarian insufficiency.

Autor: Monteiro CS; Laboratory of Human Reproduction Professor Aroldo Fernando Camargos, Hospital das Clínicas, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil., Xavier EBS; Laboratory of Human Reproduction Professor Aroldo Fernando Camargos, Hospital das Clínicas, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.; Pro Criar, Medicina Reprodutiva, Belo Horizonte, MG, Brazil., Caetano JPJ; Pro Criar, Medicina Reprodutiva, Belo Horizonte, MG, Brazil., Marinho RM; Pro Criar, Medicina Reprodutiva, Belo Horizonte, MG, Brazil.; Faculdade de Ciências Médicas de Minas Gerais, Belo Horizonte, MG, Brazil.

Publikováno v: JBRA assisted reproduction [JBRA Assist Reprod] 2020 Jul 14; Vol. 24 (3), pp. 324-331. Date of Electronic Publication: 2020 Jul 14.

Oocyte cryopreservation for future fertility: comparison of ovarian response between cancer and non-cancer patients.

Autor: Moraes CC; Pró-Criar Medicina Reprodutiva, Belo Horizonte, MG, Brazil.; Faculdade Ciências Médicas Minas Gerais, Belo Horizonte, MG, Brazil., Marinho VFW; Faculdade Ciências Médicas Minas Gerais, Belo Horizonte, MG, Brazil., Campos ALM; Pró-Criar Medicina Reprodutiva, Belo Horizonte, MG, Brazil.; Faculdade Ciências Médicas Minas Gerais, Belo Horizonte, MG, Brazil., Guedes JS; Faculdade Ciências Médicas Minas Gerais, Belo Horizonte, MG, Brazil., Xavier ÉBS; Pró-Criar Medicina Reprodutiva, Belo Horizonte, MG, Brazil.; Hospital das Clínicas da Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil., Caetano JPJ; Pró-Criar Medicina Reprodutiva, Belo Horizonte, MG, Brazil., Marinho RM; Pró-Criar Medicina Reprodutiva, Belo Horizonte, MG, Brazil.; Faculdade Ciências Médicas Minas Gerais, Belo Horizonte, MG, Brazil.

Publikováno v: JBRA assisted reproduction [JBRA Assist Reprod] 2019 Apr 30; Vol. 23 (2), pp. 91-98. Date of Electronic Publication: 2019 Apr 30.